214 related articles for article (PubMed ID: 20453212)
1. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A.
Giudice C; Ceciliani F; Rondena M; Stefanello D; Grieco V
J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical identification of canine melanocytic neoplasms with antibodies to melanocytic antigen PNL2 and tyrosinase: comparison with Melan A.
Ramos-Vara JA; Miller MA
Vet Pathol; 2011 Mar; 48(2):443-50. PubMed ID: 20858741
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of melanocytic antigen PNL2, Melan A, S100, and PGP 9.5 in equine melanocytic neoplasms.
Ramos-Vara JA; Frank CB; DuSold D; Miller MA
Vet Pathol; 2014 Jan; 51(1):161-6. PubMed ID: 23370093
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of melanoma-associated antigens on formalin-fixed, paraffin-embedded canine tumors.
Berrington AJ; Jimbow K; Haines DM
Vet Pathol; 1994 Jul; 31(4):455-61. PubMed ID: 7941235
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
Clarkson KS; Sturdgess IC; Molyneux AJ
J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers.
Busam KJ; Kucukgöl D; Sato E; Frosina D; Teruya-Feldstein J; Jungbluth AA
Am J Surg Pathol; 2005 Mar; 29(3):400-6. PubMed ID: 15725810
[TBL] [Abstract][Full Text] [Related]
7. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
[TBL] [Abstract][Full Text] [Related]
8. PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen.
Rochaix P; Lacroix-Triki M; Lamant L; Pichereaux C; Valmary S; Puente E; Al Saati T; Monsarrat B; Susini C; Buscail L; Delsol G; Voigt JJ
Mod Pathol; 2003 May; 16(5):481-90. PubMed ID: 12748255
[TBL] [Abstract][Full Text] [Related]
9. Use of immunocytochemical techniques in canine melanoma.
Höinghaus R; Mischke R; Hewicker-Trautwein M
J Vet Med A Physiol Pathol Clin Med; 2002 May; 49(4):198-202. PubMed ID: 12069262
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma.
Sulaimon S; Kitchell B; Ehrhart E
J Comp Pathol; 2002; 127(2-3):162-8. PubMed ID: 12354527
[TBL] [Abstract][Full Text] [Related]
11. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
[TBL] [Abstract][Full Text] [Related]
12. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
[TBL] [Abstract][Full Text] [Related]
13. Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells.
Oliver JL; Wolfe LG
Am J Vet Res; 1992 Jan; 53(1):123-8. PubMed ID: 1539903
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases.
Ramos-Vara JA; Beissenherz ME; Miller MA; Johnson GC; Pace LW; Fard A; Kottler SJ
Vet Pathol; 2000 Nov; 37(6):597-608. PubMed ID: 11105949
[TBL] [Abstract][Full Text] [Related]
15. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity of A103, an antibody to Melan A, in canine steroid-producing tissues and their tumors.
Ramos-Vara JA; Beissenherz ME; Miller MA; Johnson GC; Kreeger JM; Pace LW; Turk JR; Turnquist SE; Watson GL; Yamini B
J Vet Diagn Invest; 2001 Jul; 13(4):328-32. PubMed ID: 11478605
[TBL] [Abstract][Full Text] [Related]
17. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
[TBL] [Abstract][Full Text] [Related]
18. Canine melanocytes: Immunohistochemical expression of melanocytic markers in different somatic areas.
Porcellato I; Orlandi M; Lo Giudice A; Sforna M; Mechelli L; Brachelente C
Vet Dermatol; 2023 Aug; 34(4):284-297. PubMed ID: 36808650
[TBL] [Abstract][Full Text] [Related]
19. Porcine melanotic cutaneous lesions and lymph nodes: immunohistochemical differentiation of melanocytes and melanophages.
Grossi AB; Hyttel P; Jensen HE; Leifsson PS
Vet Pathol; 2015 Jan; 52(1):83-91. PubMed ID: 24503437
[TBL] [Abstract][Full Text] [Related]
20. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
